Back to NewEdge Advisors, LLC NewEdge Advisors, LLC

MNPRMNPR
10 quarters

Position history for NewEdge Advisors, LLCNewEdge Advisors, LLC's holdings in MONOPAR THERAPEUTICS INC

NewEdge Advisors, LLC holds 600 shares of MNPR (MONOPAR THERAPEUTICS INC), worth $55,554 as of 2026-Q2. MNPR represents 0.0% of NewEdge Advisors, LLC's portfolio.

Current Value

$55,554

Current Shares

600

Total Value Change

+$53,511

Total Shares Change

-2,400

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
600
0.0%
$55,5540.0%$92.59
0
2026-Q1
Unchanged
600
0.0%
$32,8740.0%$51.88
0
2025-Q4
Unchanged
600
0.0%
$39,1800.0%$65.07
0
2025-Q3
Unchanged
600
0.0%
$49,0020.0%$75.90
0
2025-Q2
Unchanged
600
0.0%
$21,4680.0%$33.60
0
2025-Q1
Unchanged
600
0.0%
$21,8460.0%$40.33
0
2024-Q4
Unchanged
600
0.0%
$13,2000.0%$23.85
0
2024-Q3
Decreased
600
-80.0%
$4,0440.0%$6.77
0
2024-Q2
Unchanged
3,000
0.0%
$2,1900.0%$3.65
0
2024-Q1
New
3,000
-
$2,0430.0%$3.40
17

Other major holders of MNPR: Janus Henderson Group Ltd., RA CAPITAL MANAGEMENT, L.P., ADAGE CAPITAL PARTNERS GP, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used